NN2211, a Novo Nordisk GLP-1 derivate, suppresses appetite in wild type but not in GLP-1R-/- mice

被引：0

作者：

Bjenning, CA ^{[1
]}

Romer, J ^{[1
]}

Knudsen, LB ^{[1
]}

机构：

[1] Novo Nordisk AS, DK-2820 Gentofte, Denmark

来源：

OBESITY RESEARCH | 2001年 / 9卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：119S / 119S

页数：1

共 50 条

[41] Acute Metabolic Effects of MEDI0382, a GLP-1/Glucagon Dual Agonist, in Wild Type and GLP-1 Receptor Knockout (GLP-1RKO) Mice
Will, Sarah E.
Naylor, Jacqueline
Rossi, Alessandra
Hornigold, David
Oldham, Stephanie
Trevaskis, James
Konkar, Anish
DIABETES, 2016, 65 : A35 - A35
[42] The long-acting GLP-1 derivative NN2211 improves glucose tolerance and normalizes body weight in diet induced obese rats
Benthem, L
Wei, L
Langer, KZ
Knudsen, LB
DIABETES, 2002, 51 : A338 - A338
[43] Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats
Larsen, PJ
Fledelius, C
Knudsen, LB
Tang-Christensen, M
DIABETES, 2001, 50 (11) : 2530 - 2539
[44] Bed-time administration of a NN2211, a long-acting GLP-1 derivative, results in a substantial reduction in fasting and postprandial glycaemia in type 2 diabetes
Juhl, CB
Hollingdal, M
Porksen, N
Sturis, J
Jakobsen, G
Schmitz, O
DIABETOLOGIA, 2001, 44 : A196 - A196
[45] The long-acting GLP-1 derivative NN2211 improves glucose tolerance and normalizes body weight in diet induced obese rats.
Knudsen, LB
Wei, L
Lange, KZ
Benthem, L
DIABETOLOGIA, 2002, 45 : A213 - A213
[46] Obese rhesus monkeys show reduced food intake and weight loss during treatment with NN2211, a long-acting GLP-1 derivative.
Hansen, BC
Izuka, M
Bjenning, C
Knudsen, LB
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (02): : 393S - 393S
[47] Synergistic effects of the dual-acting PPARα and γ agonist ragaglitazar and the long-acting GLP-1 derivative NN2211 on glycemic control in diabetic ZDF rats
Sturis, J
Gotfredsen, CF
Romer, J
Tornehave, D
Galsgaard, ED
Volund, A
Wassermann, K
Knudsen, LB
Brand, CL
DIABETES, 2002, 51 : A34 - A34
[48] Synergistic effects of the dual-acting PPARα and γ agonist ragaglitazar and the long-acting GLP-1 derivative NN2211 on glycemic control in overtly diabetic ZDF rats
Brand, CL
Gotfredesn, CF
Romer, J
Tornehave, D
Galsgaard, ED
Volund, A
Wassermann, K
Knudsen, LB
Sturis, J
DIABETOLOGIA, 2002, 45 : A60 - A60
[49] THE EFFECT OF LACTOBACILLUS RHAMNOSUS GG ON THE GLP-1/GLP-1R AXIS AND GUT MICROBIOTA IN OBESE MICE
Wang, Xu
Wang, Sipu
Cao, Hailong
Zhang, Jie
Xu, Xin
GASTROENTEROLOGY, 2024, 166 (05) : S1534 - S1534
[50] Effects of Orally Active GLP-1 Analog (ro1-GLP-1) in Type II Diabetes Mice Models
Wong, Patrick Y.
Hou, Jianhua
Ren, Fujin
Li, Minggang
DIABETES, 2009, 58 : A134 - A134

← 1 2 3 4 5 →